EPAS1 and nonpapillary renal cell carcinoma: Recent data suggest that the mTORC2 pathway is important for HIF-2α translation,31, 32 suggesting that dual mTORC1/2 kinase inhibitors may be more beneficial for metastatic ccRCC than rapamycin analogs.